Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor-associated proteases are a diverse group of enzymes that are overexpressed or aberrantly activated in the tumor microenvironment. They play critical roles in cancer progression, including tumor growth, invasion, metastasis, angiogenesis, and modulation of the immune response. These proteases can originate from both cancer cells and stromal components such as cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs. Examples include uPA, MMPs, cathepsins and FAP. They are attractive targets for diagnostic imaging agents, prodrug therapies, antibody-drug conjugates, and direct enzyme inhibitors.
Inhibition of protease activity, blocking downstream signaling pathways, targeted drug delivery via protease-cleavable linkers
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor-Associated Proteases.